FMR CORP 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 10:06 am Unchanged |
2024-04-09 | 13G | Regulus Therapeutics Inc. RGLS |
FMR CORP | 2,922,600 4.464% |
0 (Unchanged) |
Filing |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Regulus Therapeutics Inc. RGLS |
FMR CORP | 2,922,600 14.452% |
727,600 (+33.15%) |
Filing |
| 2022-10-11 09:03 am Purchase |
2022-10-07 | 13G | Regulus Therapeutics Inc. RGLS |
FMR CORP | 2,195,000 14.998% |
2,195,000 (New Position) |
Filing |